Clinical trials: Subarachnoid Neurocysticercosis
Subarachnoid Cysticercosis
RCT ALB for SA Cysticercosis
This study will enroll 120 individuals diagnosed with subarachnoid cysticercosis, a disease caused by the invasion of the basal part of your brain by a parasite named Taenia solium.
- Trial name
- NCT00133458
- Testing
- Albendazole
- Where
- 4 sites in Brazil, Colombia and 2 more
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Subarachnoid Neurocysticercosis
SANCC: Clinical Trial Early Intervention
Subarachnoid neurocysticercosis (SANCC) is a severe infection of the brain by the tapeworm Taenia solium. People who have this infection are usually diagnosed late in the disease process leading to very poor prognosis.
- Trial name
- NCT03950037
- Testing
- Albendazole
- Sponsor
- Oregon Health and Science University
Neurocysticercosis
Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)
Taenia solium neurocysticercosis (NCC) is a parasitic infection causing much neurological disease in most of the world. When parasites locate in the cavities around the brain (subarachnoid NCC, SANCC), it becomes an aggressive…
- Trial name
- SANTO (NCT02947581)
- Testing
- Albendazole and praziquantel
- Where
- 2 sites in Peru
- Volunteers
- 107 people
- Sponsor
- Universidad Peruana Cayetano Heredia